Investment analysts at JMP Securities initiated coverage on shares of Addus HomeCare (NASDAQ:ADUS - Get Free Report) in a report released on Monday,Briefing.com Automated Import reports. The brokerage set an "outperform" rating and a $150.00 price target on the stock. JMP Securities' price target suggests a potential upside of 20.00% from the company's current price.
Several other analysts also recently issued reports on the company. Royal Bank of Canada restated an "outperform" rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Stephens raised their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an "overweight" rating and a $150.00 target price on the stock. StockNews.com upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Wednesday, December 11th. Finally, Macquarie reaffirmed an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare currently has an average rating of "Moderate Buy" and a consensus price target of $133.67.
Check Out Our Latest Stock Analysis on ADUS
NASDAQ:ADUS opened at $125.00 on Monday. The firm's fifty day moving average price is $125.64 and its two-hundred day moving average price is $124.55. The company has a market cap of $2.27 billion, a P/E ratio of 28.60, a P/E/G ratio of 2.11 and a beta of 1.01. Addus HomeCare has a one year low of $85.94 and a one year high of $136.12.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. During the same period in the prior year, the firm earned $1.03 EPS. The business's revenue was up 7.1% on a year-over-year basis. As a group, equities research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.
In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company's stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company's stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company's stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Franklin Resources Inc. lifted its stake in Addus HomeCare by 2.7% during the 3rd quarter. Franklin Resources Inc. now owns 26,216 shares of the company's stock valued at $3,456,000 after acquiring an additional 701 shares in the last quarter. Hohimer Wealth Management LLC purchased a new stake in shares of Addus HomeCare in the third quarter valued at about $299,000. Geode Capital Management LLC boosted its holdings in Addus HomeCare by 7.1% during the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company's stock worth $56,406,000 after purchasing an additional 28,284 shares during the last quarter. Barclays PLC increased its stake in Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock valued at $5,783,000 after buying an additional 29,207 shares during the last quarter. Finally, EP Wealth Advisors LLC bought a new position in shares of Addus HomeCare during the 3rd quarter worth approximately $249,000. 95.35% of the stock is owned by institutional investors.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.